The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Soignet, S.L., P. Maslak, Z.G. Wang, S. Jhanwar, E. Calleja, L.J. Dardashti, D. Corso, A. DeBlasio, J. Gabrilove, D.A. Scheinberg, P.P. Pandolfi, and R.P. Warrell, Jr. 1998. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339:1341-1348.
Stockman, R. 1902. The therapeutic value of arsenic and the justification of its continued use in the light of recent observations concerning its toxic action. Br. Med. J. (Oct. 18):1227-1229.
Underwood, E.J. and W. Mertz. 1987. Introduction. Pp. 1-19 in Trace Elements in Human and Animal Nutrition, Vol. 1, 5th Ed., W. Mertz, ed. San Diego, Calif.: Academic.
Uthus, E.O. 1992. Evidence for arsenic essentiality. Environ. Geochem. Health 14:55-58.
Uthus, E.O., W.E. Cornatzer, and F.H. Nielsen. 1983. Consequences of arsenic deprivation in laboratory animals. Pp. 173-189 in Arsenic: Industrial, Biomedical, Environmental Perspectives, W.H. Lederer and R.J. Fensterheim, eds. New York: Van Nostrand Reinhold.
Vahter M., and H. Norin. 1980. Metabolism of 74 As-labeled trivalent and pentavalent inorganic arsenic in mice. Environ. Res. 21:446-457.